INVES 21

Trend of Stock Market

A trend is the broad upward or downward movement of a stock's price over time

Forthcoming IPO Open Issues Closed Issue
Forthcoming Issues Open Issues Closed Issue
World Indices ADR Prices MF Investment FII Investment
Get Quotes Company Snapshot Company Background Board of Directors Directors Reports Profit & Loss Balance Sheet Quarterly Results Shareholding Pattern Key Financial Ratios Mutual Fund Holdings Peer Comparison Technical Chart

Profit & Loss

Change Company Name

Glenmark Pharmaceuticals Ltd

Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code 532296	ISIN Demat INE935A01035	Book Value 848.31	NSE Symbol GLENMARK	Dividend Yield (%) 0.13	Market Cap (₹ Cr.) 55,707.85	P/E 37.86	EPS 52.14	Face Value 1

Particulars (₹ Cr)	Mar2025	Mar2024	Mar2023	Mar2022	Mar2021
Revenue From Operations	9,226.41	7,891.12	8,220.66	8,141.58	7,567.93
Sale of Products	8,988.47	7,627.81	7,998.18	7,991.98	7,424.98
Sale of Services	22.07	21.95	21.49	25.40	25.93
Income from Investment and Financial Services	0.00	0.00	0.00	0.00	0.00
Income from Insurance Operations	0.00	0.00	0.00	0.00	0.00
Other Operating Revenue	215.87	241.36	201.00	124.20	117.02
Less: Excise Duty / GST	0.00	0.00	0.00	0.00	0.00
Revenue From Operations - Net	9,226.41	7,891.12	8,220.66	8,141.58	7,567.93
Other Income	356.37	1,168.02	985.94	614.63	396.24
Total Revenue	9,582.78	9,059.14	9,206.60	8,756.21	7,964.17
Changes in Inventories	44.48	-103.07	-31.37	-16.13	5.24
Cost of Material Consumed	2,781.45	2,990.41	3,035.88	2,993.04	2,678.26
Internally Manufactured Intermediates Consumed	0.00	0.00	0.00	0.00	0.00
Purchases of Stock-in-Trade	373.21	322.78	391.19	481.62	315.96
Employee Benefits	1,603.50	1,434.78	1,346.51	1,193.20	1,107.40
Total Other Expenses	2,179.60	2,004.56	2,005.68	1,801.64	1,570.74
Manufacturing / Operating Expenses	368.99	372.71	303.56	298.10	221.14
Administrative and Selling Expenses	1,423.29	1,306.69	1,342.28	1,153.58	991.30
Other Expenses	387.32	325.15	359.85	349.97	358.30
Finance Costs	48.73	277.11	206.82	236.04	265.90
Depreciation and Amortization	218.63	202.16	184.15	159.70	150.82
Total Expenses	7,249.59	7,128.73	7,138.86	6,849.10	6,094.31
Profit Before Exceptional Items and Tax	2,333.18	1,930.42	2,067.74	1,907.11	1,869.87
Exceptional Items Before Tax	-179.17	5,070.33	-495.87	430.33	73.89
Profit Before Extraordinary Items and Tax	2,154.02	7,000.75	1,571.87	2,337.45	1,943.76
Extraordinary Items Before Tax	0.00	0.00	0.00	0.00	0.00
Other Adjustments Before Tax	0.00	0.00	0.00	0.00	0.00
Profit Before Tax	2,154.02	7,000.75	1,571.87	2,337.45	1,943.76
Taxation	543.67	1,833.46	363.11	339.66	294.31
Current Tax	316.09	1,049.99	386.93	411.08	343.62
MAT Credit Entitlement	0.00	0.00	0.00	0.00	0.00
Deferred Tax	227.58	783.46	-23.83	-71.42	-49.31
Other Tax	0.00	0.00	0.00	0.00	0.00
Adjust for Previous Year	0.00	0.00	0.00	0.00	0.00
Profit After Tax	1,610.35	5,167.29	1,208.77	1,997.79	1,649.45
Extraordinary Items After Tax	0.00	0.00	0.00	0.00	0.00
Discontinued Operations After Tax	0.00	0.00	0.00	0.00	0.00
Profit / (Loss) from Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Tax Expenses of Discontinuing Operations	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Shareholders	1,610.35	5,167.29	1,208.77	1,997.79	1,649.45
Adjustments to Net Income	0.00	0.00	0.00	0.00	0.00
Preference Dividend	0.00	0.00	0.00	0.00	0.00
Profit Attributable to Equity Shareholders	1,610.35	5,167.29	1,208.77	1,997.79	1,649.45
Earning Per Share - Basic	57.07	183.13	42.84	70.80	58.46
Earning Per Share - Diluted	57.07	183.12	42.84	70.80	58.46
Operation Profit before Depreciation	2,600.55	2,409.69	2,458.71	2,302.85	2,286.58
Operating Profit after Depreciation	2,381.92	2,207.53	2,274.56	2,143.15	2,135.76
Dividend Per Share	2.50	2.50	2.50	2.50	2.50
Dividend Percentage	250.00	250.00	250.00	250.00	250.00
Equity Dividend	70.55	70.55	70.54	70.54	70.54
Weighted Average Shares - Basic	28.22	28.22	28.22	28.22	28.22
Weighted Average Shares - Diluted	28.22	28.22	28.22	28.22	28.22